New research reveals that patients who come off new weight-loss injections like semaglutide or tirzepatide tend to recover reduced body mass much more quickly than those who end conventional lifestyle regimens.
Research printed in a leading medical journal shows that while overweight people frequently drop substantial amounts of their total mass while using the jabs, the mass comes back at an estimated rate of 0.8 kg per month after stopping.
"People using such medications need to be cognizant of the danger of quick weight regain when the therapy concludes," stated researcher Dr. Susan Jebb.
That rate of regain means a reversion to pre-treatment weight in about a year and a half.
Comparing Therapies
The research, which looked at 37 of studies involving over 9,000 of patients, compared the results of the injectable medications with older methods.
The team emphasize that people who lose weight through lifestyle changes alone typically experience a less rapid weight regain—perhaps 100 grams monthly—post-intervention.
The Reason for the Rapid Rebound
Experts believe the mechanism of the drugs is key to understanding the amplified regain.
These medications copy a natural hormone called glucagon-like peptide-1, which controls feelings of fullness.
"Sustained high doses of GLP-1 levels several times higher than the body's typical production may cause the body to generate a reduced amount of its own natural GLP-1, and could lessen sensitivity to its actions," explained Dr. Adam Collins, a nutrition specialist.
"Withdrawal of this medication leads to hunger is uncontrolled, making binge eating far more likely."
A Lifelong Disease?
Medical guidelines advise the jabs for people with weight-linked health risks, alongside recommended diet and exercise modifications.
Professionals contend that, given the likelihood of weight regain, the therapy should be considered ongoing.
This view is reinforced by drug manufacturers, who say that the results "underscore the long-term character of obesity," akin to managing conditions like high blood pressure.
User Experiences
Individuals who have stopped the medication report a sudden return of appetite.
"It was like something flipping and you're instantly starving," said a patient.
This difficulty is worsened if users have not adopted permanent lifestyle or habit changes during therapy.
Growing Adoption
Figures indicate that millions of adults in the UK have tried weight-loss jabs in the last 12 months, with interest continuing to grow.
- Use is higher among females than men.
- The middle-aged age group shows the highest usage rates.
- A large proportion obtain the drugs through private healthcare rather than public health services.
In conclusion, experts caution that while these medications are potent tools for shedding pounds, they are not a magic fix and maintained weight loss likely depends on combined behavioural support.
